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RESEARCH ARTICLE Open Access
Time-to-infection by Plasmodium falciparum is
largely determined by random factors
Mykola Pinkevych1, Kiprotich Chelimo2, John Vulule2, James W Kazura3, Ann M Moormann4 and Miles P Davenport1*
Abstract
Background: The identification of protective immune responses to P. falciparum infection is an important goal for
the development of a vaccine for malaria. This requires the identification of susceptible and resistant individuals,
so that their immune responses may be studied. Time-to-infection studies are one method for identifying putative
susceptible individuals (infected early) versus resistant individuals (infected late). However, the timing of infection is
dependent on random factors, such as whether the subject was bitten by an infected mosquito, as well as individual
factors, such as their level of immunity. It is important to understand how much of the observed variation in infection
is simply due to chance.
Methods: We analyse previously published data from a treatment-time-to-infection study of 201 individuals aged 0.5
to 78 years living in Western Kenya. We use a mathematical modelling approach to investigate the role of immunity
versus random factors in determining time-to-infection in this cohort. We extend this analysis using a modelling
approach to understand what factors might increase or decrease the utility of these studies for identifying susceptible
and resistant individuals.
Results: We find that, under most circumstances, the observed distribution of time-to-infection is consistent with this
simply being a random process. We find that age, method for detection of infection (PCR versus microscopy), and
underlying force of infection are all factors in determining whether time-to-infection is a useful correlate of immunity.
Conclusions: Many epidemiological studies of P. falciparum infection assume that the observed variation in infection
outcomes, such as time-to-infection or presence or absence of infection, is determined by host resistance or
susceptibility. However, under most circumstances, this distribution appears largely due to the random timing of
infection, particularly in children. More direct measurements, such as parasite growth rate, may be more useful
than time-to-infection in segregating patients based on their level of immunity.
Keywords: Blood-stage immunity, Malaria, Mathematical modelling, Plasmodium falciparum, Time-to-infection
Background
Infection with Plasmodium falciparum (P. falciparum)
causes over 1 million deaths each year [1]. The risks of
death and clinical illness is highest in young children
(<5 years old), whereas adults living in endemic areas
show reduced prevalence of infection, reduced parasit-
emia, and reduced incidence of clinical illness. This resist-
ance to infection and illness with age is often referred to
as ‘naturally acquired immunity’, and understanding the
mechanisms of this may facilitate the development of a
vaccine for the control of malaria. Studies of naturally
acquired immunity rely on identifying variation in sus-
ceptibility in the population, and then characterizing the
differences in immune responses between susceptible and
resistant individuals. If immune responses associated with
resistance can be identified, these may provide useful
targets in the development of vaccines.
A key feature in the study of naturally acquired immunity
is the identification of individuals that are relatively pro-
tected from infection or illness. If immune responses can
be characterized at baseline, and subsequent infection rates
identified, then it is possible to retrospectively identify
those responses most closely associated with protection.
Prospective cohort studies offer the opportunity to meas-
ure immune responses at baseline, and investigate these as
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predictors of either infection (parasitemia) or clinical illness.
Susceptibility may be measured as either the presence or
absence of infection or clinical episodes in a fixed time
period, the number of episodes in a period, or the time to
an episode. An alternative approach to studying malaria
susceptibility and resistance is through a prospective study
of time-to-infection in a cohort of individuals treated to
eliminate malaria, and then undergoing natural exposure in
an endemic setting. By observing which baseline immuno-
logical factors predict a delay in the time-to-infection, it is
hoped to detect protective immune responses. Such studies
have been used to explore the relationship between anti-
body responses and protection from both infection and
clinical episodes [2-4].
Although these are generally referred to as time-to-
infection studies, very different results can be obtained
depending on whether infection is detected by microscopic
examination of blood, or more sensitive PCR techniques
[5-7]. Since these two techniques give different times of
‘infection’, it is probably more accurate to discuss these
studies as measuring ‘time-to-detection’ of infection
(using a particular detection method). Thus, it is import-
ant to understand that current ‘time-to-infection’ studies
are always measuring ‘time-to-detection’. If we had a
sensitive enough assay, the time of initiation of infection
and time of detection would coincide. However, in the
absence of this, we will use the term ‘time-to-initiation’
to refer to the time until initiation of blood-stage infec-
tion, and ‘time-to-detection’ to refer to what is usually
described as ‘time-to-infection’.
In time-to-infection (detection) studies a major assump-
tion is that delayed acquisition of infection (or clinical
disease) is the result of the level of immune protection.
However, the timing of when infection or disease is first
detected depends on two major factors. The first is the
random timing of when a particular individual experiences
a new infection (from an infectious bite from a mosquito).
The second factor is how the immune system subse-
quently modifies the outcome of the bite to determine
whether and when infection or clinical illness is detected.
For example, liver stage immunity may reduce the prob-
ability that an infectious mosquito bite results in a blood-
stage infection (and only a small fraction of infected
mosquito bites are thought to reach the blood stage [8,9]).
Similarly, blood-stage immunity may delay the timing
of parasite detection or clinical illness after the initiation
of blood-stage infection, and may reduce the peak levels
of parasite or the clinical manifestations of infection [5]. It
is generally assumed that immunity plays a role in deter-
mining differences in time-to-infection, and thus that
time-to-infection can be used as a correlate of immunity
[2-4]. The major effect of pre-erythrocytic immunity
would be to delay the average time-to-initiation of infec-
tion. Blood-stage immunity would not change time-to-
initiation, but would change time-to-detection, because
slower parasite growth would increase the delay between
initiation and detection.
We have previously analysed the mechanisms of natur-
ally acquired immunity by studying the dynamics of
infection of individuals of different ages [5]. We found
that the growth rate of parasites in blood-stage infection
decreased with age and that this decrease in growth rate
explains the differences in time-to-detection observed
in individuals of different ages [5,10]. Our modelling
suggested that time-to-initiation of blood-stage infection
was not significantly different between age groups, and thus
found little evidence for pre-erythrocytic immunity delaying
time to initiation. By contrast, we found a decreased blood-
stage growth with age and that this decreased growth
explained the delayed time-to-detection with age. Under-
standing how heterogeneity in blood-stage immunity
and parasite growth rate affect time-to-infection studies
is important to interpreting immune correlates arising
from these studies.
Herein, we have analysed the kinetics of infection in a
treatment-time-to-infection (detection) study performed
in Kenya [2], in order to understand the ability of this
approach to identify differences in susceptibility or resist-
ance to infection. We argue that, in most cases, the major
factor that determines the time-to-detection is simply the
random timing of when infection happened to be initiated.
We show that, depending on the age cohort and method
used to detect infection, stratifying individuals based on
time-to-detection will not be useful in identifying individ-
uals who are more susceptible or immune to infection. As
a result, the timing of infection between individuals often
carries little information about the level of immunity of
the individuals concerned. We illustrate how the sensitiv-
ity of the method of detection of parasites can also play an
important role in determining how powerful this tech-
nique is at estimating the level of immune protection;
paradoxically, the higher the sensitivity of the detection
method, the lower the ability to discern differences in
parasite growth rate. Overall, our analysis suggests that
time-to-infection studies need to be interpreted with
caution, and alternative approaches such as direct meas-
urement of parasite growth rate may be much more
sensitive at detecting differences in acquired immunity
to P. falciparum infection.
Methods
Field study
We analysed the data from a field study of a cohort of
201 individuals aged 0.5 to 78 years old living in a malaria
holoendemic region of western Kenya [11]. This popula-
tion has a high incidence of P. falciparum infection, which
we have recently estimated as a new blood-stage infection
approximately every 2 weeks [10]. Subjects were treated
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with Coartem®, which acts against blood-stage infection but
does not affect liver-stage parasites [12]. After treatment,
blood smears were monitored weekly for 11 weeks for
presence of P. falciparum parasites by light microscopy.
Individuals were removed from the study if they were
found microscopy-positive by week 2 after treatment (due
to presumed treatment failure) or if weekly samples were
not collected after the second week of treatment, thus
leaving 197 individuals for analysis. Blood samples were
also later analysed using a nested polymerase chain reac-
tion (PCR) approach to measure low levels of infection
[7]. The PCR analysis was performed post-hoc and thus
did not affect the inclusion criteria for the field study. This
data was previously analysed to estimate growth rates of
P. falciparum in vivo [5,10].
Directly estimating the growth rate using PCR and
microscopy data
We can assess the growth rate expressed as parasite
multiplication rate (PMR) in individuals using the time
between PCR and microscopy detection for each individual.
However, we cannot estimate the growth rate precisely,
since our PCR measurement shows only the presence or
absence of parasites above a threshold, rather than the
concentration of parasites.
In order to investigate the PMR with different times-
to-detection, we estimated the minimal PMR for each
individual using the PCR and microscopy data (Figure 1A
and B, respectively). Briefly, we identify the time of the
first positive detection of parasites by PCR (tPCR) and
the first detection by microscopy (tmicro), and the last
week when the PCR was negative (tPCR – 7). We assume
a parasite density of 40 parasites/μL as the microscopy
detection threshold (Tmicro), and a density of 0.12 para-
sites/μL as the PCR detection threshold (TPCR) [5,13,14],
and use the actual density of parasites at microscopy
detection (Dmicro). We then estimate the parasite growth
rates (PMRs), depending on the relative timing of tPCR
and tmicro. If tPCR = tmicro (i.e., parasites were first de-
tected by PCR and microscopy on the same week), then
r = (Dmicro/TPCR)
2/7 (i.e., we assume growth from the
PCR threshold to the microscopy value over the week
before detection). Where tPCR < tmicro (as was usually the
case), then we know that i) parasite density was between
TPCR and Tmicro at tPCR, and ii) parasite density was <
TPCR at (tPCR – 7). Assuming the real parasite density
was at the upper limit of these ranges (i.e., is at Tmicro at
tPCR, and at TPCR at (tPCR – 7)), we can obtain a conser-
vative estimate of PMR, and take the larger of the two
estimates. Thus,
r ¼ max Dmicro=Tmicroð Þ2= tmicro−tPCRð ÞÞ;
Dmicro=TPCRð Þ2= tmicro−tPCR−7ð Þ ÞÞ
ð1Þ
We note, that some individuals are PCR positive, but
do not become microscopy positive before the end of
the study (tmax). In this case, we assume that parasite
concentration was at the microscopy detection threshold
at the last week of study and estimate a maximal PMR,
r = (Tmicro/TPCR)
(2/(tmax – tPCR – 7)).
Modelling the infection curve
In previous studies, we showed that the distribution of
time to detection of infection in the different age groups
are consistent with the measured reduction in PMR with
age, leading to a delay in the time until the detection of
infection, as well as a reduced peak of parasitaemia [5,10].
We assumed that parasites have exponential growth from
the time of initiation of blood-stage infection, and a life
cycle of 2 days. Thus, the concentration of parasites in
blood can be described by the formula:
C tð Þ ¼ C 0ð Þrt=2 ð2Þ
Where r is the PMR, C is the concentration of parasites
per μL, t is the time (in days) from the initiation of blood-
stage infection (t = 0). We note that the concentration of
parasites at emergence from the liver is adjusted by blood
volume in each age group. In order to find the average
blood volumes in age groups (V1 = 1.1 × 10
6 μL, V2 = 2 ×
106 μL, V3 = 3.3 × 10
6 μL, V4 = 5 × 10
6 μL), we used
Chart 1 in reference [15]. The number of merozoites
released from the liver for a single bite we estimated as
5.6 × 104 [13].
In the model, we assume that bites occur randomly
with exponentially distributed times between infective
bites. However, we can only detect infection after the
delay θ(r) due to blood-stage parasite replication until
the parasitemia reaches the detection threshold. This
delay is equal to:
Figure 1 Treatment-time-to-infection studies. The results of a
previously published treatment-time-to-infection cohort study in
Kenya are shown [2]. Parasites were detected by either microscopy
(A) or PCR (B). Black shapes are data (joined by dashed lines). Black
squares, blue lines – children 1 to 4 years old (y.o.); circles, green
line – children 5 to 9 y.o.; triangles, orange line – children 10 to 14 y.o.;
diamonds, red line – adults >14 y.o. The solid blue line is the result of
fitting the exponential decay model for children 1 to 4 years old.
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θ rð Þ ¼ 2 logrT=C 0ð Þ
where r is the PMR and T is the detection threshold
(microscopy or PCR).
Assuming that the PMR is the same within age groups,
we obtain the exponential decay curve until detection
with initial plateau due to growth of parasites until
detection.
S tð Þ ¼ e
−λ t−2 logrT=C 0ð Þ−τð Þ; t > 2 logrT=C 0ð Þ þ τ
1; t≤2 logrT=C 0ð Þ þ τ

ð3Þ
The constant τ = 7 days is the first day blood-stage
infection could be initiated after treatment due to the
pharmacodynamics of lumefantrine [12,16-22], λ is the
rate of initiation of the blood-stage infection.
We also assumed that PMR has a normal distribution
within a group of people of approximately the same age
with mean m and standard deviation βm, where β is a
positive constant. This normal distribution of growth
rates is consistent with the observed data, however, the
precise shape of the distribution is not critical to the
conclusions. Functions f(r) and F(r) are the probability
density function and the cumulative density function of
a normal distribution, respectively. Constant rmax is a
maximal number of newly infected red blood cells that
can be infected by one infected red blood cell.
The model that describes the infection curve with the
delay to detection is defined by formula:
S tð Þ ¼ F 1ð Þ þ 1=F rmaxð Þ
Zrmax
1
e−λmax t−Θ rð Þ−τ;0ð Þf rð Þdr
ð4Þ
This formula incorporates the initial delays to detec-
tion in exponential decay function for all possible PMRs
weighted by the probability of a given PMR. The terms
in front of the integral appear due to truncation of the
Normal distribution at rmax (we assumed maximal PMR
is 32 per cycle) and assumption that infections with
PMR ≤1 would never be detected (function tends to
plateau at F(1)).
In the current study, using assumptions of model (1),
we want to find the distribution function h(r) of the
PMR for people who were detected positive by PCR or
microscopy in a given time window (t1,t2). For this
purpose, we need to multiply the distribution function
of the PMR f(r), for the whole group by the ‘fraction’ of
people with given PMR in this time window, i.e., people
who had initiation of blood-stage infection θ(r) days ago.
The distribution of the PMR h(r) in the given time
window can be found by the formula:
h rð Þ ¼ kf rð Þ
Zt2
t1
fexp t−Θ rð Þð Þdt
¼ kf rð Þ eλmax t1−Θ rð Þ;0ð Þ−eλmax t2−Θ rð Þ;0ð Þ
 
ð5Þ
The function fexp(t – Θ(r)) is the exponential distribution
function that describes the initiation of blood-stage infec-
tion Θ(r) days before detection. The constant k normalizes
the expression to make h(r) satisfy the condition of the




f rð Þ e−λmax t1−Θ rð Þ;0ð Þ−e−λmax t2−Θ rð Þ;0ð Þ
 
dr
The influence of PMR on delay to detection by PCR and
microscopy and the difference in distributions of PMR in
individuals detected earlier and later after treatment is
described in the model above and is schematically illus-
trated in Figure 2.
Results
Time-to-detection in children is a random process
We first focused on the kinetics of infection of the youn-
gest children in the cohort, aged 1 to 4 years (Figure 1A,
in blue). Using detection of parasites by light microscopy,
our sensitivity of detection was around 40 parasites
per μL. Using this method of detection, we found that
time-to-detection in these children varied from 3 weeks
to 11 weeks. In order to determine whether this was a
random process, we modelled time-to-detection as an
exponential process using formula (3). That is, once we
allow for a delay from treatment (for washout of lume-
fantrine, and the time taken for the parasites to grow to
the level of detection), we found that the rate of detection
of infection was consistent with an exponential process,
with a rate of new infections (λ) of 0.066/day (95% CI,
0.056–0.076) (Figure 1). This equates to a ‘half-life’ (time
until half the children are infected) of approximately
10 days. The exponential curve is indicative of a stochastic
process, with all individuals at equal risk at all times. The
close fit of the data to this model suggests that the timing
of detection in these children is a random process, equiva-
lent to radioactive decay. Thus, time-to-detection of an in-
dividual child carries essentially no information about the
susceptibility of that child. The time-to-detection in these
children is determined by the random time-to-initiation
(of infection), and can be explained simply as a stochastic
process, dependent on the time of biting.
To confirm this, we investigated whether children
infected early or late differed in their subsequent infection
kinetics. The blood-stage growth rate of the parasite is
one factor determining when infection will be detected.
Faster growing parasites should take a shorter time from
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emergence in the liver to reaching the detection threshold.
If growth rate were the only (or major) factor determining
time of detection, then early detection should be associated
with faster growth, and late detection with slow growth.
However, if time-to-detection is due to the random time-to-
initiation of infection (as suggested above), then blood-stage
growth rate will not be correlated with time-to-detection.
One measure of blood-stage parasite growth is the
time between PCR detection and microscopy detection,
since this will be longer for slower growing parasites.
We measured the delay between detection of parasitemia
by PCR and by microscopy in children who were infected
early (parasites first detected by microscopy in weeks 3 to
4 of the study) versus children infected late (weeks 5 to 9).
We found no significant difference in the delay between
PCR and microscopy detection in children infected early
versus late (Figure 3A). We also estimated the growth rate
of parasites in the same group of children (using the time
of PCR detection and the level of parasitemia at micros-
copy detection, and equation (1)) and again found that
children with different time-to-detection did not differ
significantly in growth rates (Figure 3B). This suggests that
blood-stage growth rate of P. falciparum is not a major
determinant of time-to-detection in children or, con-
versely, that time-to-detection does not sort children
based on the growth rate of blood-stage infection.
Time to microscopy-detectable infection in adults is
associated with parasite growth rate
We have previously shown that adults within this cohort
had significantly different time-to-detection compared to
children [5,10]. The survival curves of adults do not
conform to a simple exponential reinfection process,
suggesting a greater role for possible infection-modifying
immune responses. Two possible mechanisms are likely
to modify the time-to-detection: differences in liver-stage
immunity (reducing the rate of initiation of infections), or
differences in blood-stage immunity, affecting the time
from liver emergence to detection of infection. We have
previously demonstrated that the survival curves can be
explained by heterogeneity in the growth rates of parasites
in blood. If time-to-detection were caused by differences
in liver-stage immunity, then we would expect no differ-
ence in parasite growth rate according to time of infection.
Figure 2 Schematic of time-to-infection model. (A) Given a
constant force of infection, the time-to-initiation of blood-stage infection
is exponentially distributed. (B) After emergence from the liver, there is
a distribution of parasite growth rates (shaded purple triangles). (C)
Parasites grow until they reach the threshold for detection by PCR (red
dots and lines) or microscopy (green dots and lines). It is then possible
to compare the growth rates for individuals detected early (blue box in
C, blue-shaded shape in D) or late (yellow box in C, yellow-shaded
shape in D).
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However, if blood-stage growth rate plays a role, then we
expect that adults with a longer time-to-detection would
have slower parasite growth rates. Thus, we studied indi-
viduals aged >15 years in the cohort, focusing on individ-
uals infected early (weeks 4 to 6) or late (weeks 8 to 11).
Note that the designation of ‘early’ and ‘late’ infection
differed considerably between children and adults, due to
the different timing of detection in the different groups.
In this adult population, we find that adults with longer
time-to-detection (by microscopy) have a significantly
greater delay between PCR detection and microscopy
detection (median 0.5 weeks versus 4 weeks, P value =
0.0002; Figure 3C). Using the levels of parasitemia at
microscopy detection and applying formula (1), we also
estimated the growth rate of parasites in adults infected
early and late, and found significantly slower growth in
adults infected late (median 5.156 per 2-day cycle versus
1.561, P = 0.0004; Figure 3D). This indicates that time-to-
detection by microscopy carries information on the kinet-
ics of blood-stage parasite growth in this adult population.
Use of more sensitive testing reduces the ability to
discriminate differences in parasite growth rate
In addition to screening samples for infection by micros-
copy, we also screened samples by PCR. In the case of
the children’s cohort, the shape of the reinfection curve
remained exponential, despite an overall predisposition
for infection to be detected earlier (Figure 1A,B, dark
blue dashed lines). In the case of the adults, the shape of
the time-to-detection curve is significantly altered when
infection is detected by PCR (Figure 1A,B, red dashed
lines). The more sensitive detection threshold of PCR
causes the curve to become, overall, much more like an
exponential curve. Using this data, we again stratified in-
dividuals based on time-to-detection among the children
and adults, this time grouping early and late according
to time of PCR detection (Figure 4). In both adults and
children, there were sometimes long delays from PCR to
microscopy detection. A large proportion of adults were
PCR positive but were not detected by microscopy. In
order not to bias the ‘late-infected cohort’ we only esti-
mated delays/growth rates where this could be measured
in both the early and late cohorts (i.e., within 3 weeks of
detection by PCR in adults and 5 weeks in children).
In the children aged 1 to 5, we studied infection kinetics
in individuals becoming PCR-positive in weeks 1 to 3 ver-
sus weeks 4 to 6. We observed no significant differences
in either the delay between PCR positivity and microscopy
positivity, or in the estimated PMR (Figure 4A,B). In
adults aged >14 years we performed a similar analysis, this
Figure 3 Time-to-microscopy-detection and parasite growth rate. Individuals were grouped according to the time at which parasites were
first detected by microscopy. The time between PCR detection and microscopy detection was directly measured from the data for each patient.
Parasite growth rates were estimated from the time of PCR detection to time and level of microscopy detection, using equation (1). This allowed
us to compare both delays and PMR in early-detected versus late-detected groups. For children, neither the delay (A) nor the growth rate (B)
was significantly different between early and late-infected groups (timing of detection shown in E). For adults, there was a significantly longer
delay (C), and slower growth rate (D) in the late-infected group (timing of detection shown in F).
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time comparing those who became PCR-positive in weeks
2 to 4 and in weeks 6 to 8. Here, we observed that individ-
uals becoming PCR-positive later had a reduced time
between PCR and microscopy detection (P = 0.0185) and
an associated increased PMR (P = 0.0238). This is unex-
pected, as late-detected individuals are expected to have
slower parasite growth. A confounding factor here may be
the high proportion of adults who were detected as PCR-
positive, but did not become microscopy-positive during
the study. For these individuals we can only estimate a
‘minimum delay’ and ‘maximum growth rate’.
Modelling time-to-detection
The analysis presented above demonstrates that the use
of time-to-detection to classify individuals as susceptible
or resistant to infection can be problematic in our study.
This is because the random factor of when infection is
initiated is often the major factor determining the time-
to-detection. However, our study included a particular
distribution of ages and number of individuals studied.
Therefore, to illustrate the problem more generally, we
used a modelling approach to look at how parasite
growth rate and parasite detection method interact to
determine how informative time-to-detection data is.
We have previously illustrated that parasite growth is
the major factor that differs between age groups in the
field study. By varying only the average parasite growth
rate for different age groups and assuming a normal dis-
tribution of growth rates within an age group, we found
we could simultaneously fit both the PCR-determined
and microscopy-determined time-to-infection curves
[5,10]. These predicted differences in parasite growth
rate with age were also supported by direct estimation of
parasite growth rates using PCR and microscopy data
for different individuals. Figure 5A,B shows the fitting of
the survival curves to the microscopy and PCR detection
datasets. The same model, using the predicted distribu-
tion of growth rates, was then used to understand
whether time-to-detection was useful at identifying dif-
ferences in parasite growth rate between ‘early infected’
and ‘late infected’ groups.
In order to illustrate the interaction of parasite growth
rate and time-to-detection, we divided the youngest and
oldest age cohorts (blue and red lines, respectively, in
Figure 5A,B) into three groups according to time-to-
detection (indicated by grey shading in Figure 5A,B).
Then, we used the model to predict the expected growth
rate distribution for individuals infected early (14 to
Figure 4 Time-to-PCR detection and parasite growth rates. Individuals were grouped according to the time at which parasites were first
detected by PCR. The time between PCR detection and microscopy detection was measured, and PMR estimated, in order to compare parasite
growth rates in early-detected versus late-detected groups. For children, neither the delay (A) nor the growth rate (B) was significantly different
between early- and late-infected groups (timing of detection shown in E). For adults, there was a significantly shorter delay (C) and faster growth
rate (D) in the late-infected group (timing of detection shown in F). Grey symbols in panels A–D and open circles in panels E and F indicate
where parasites were not detected by microscopy before the end of the study. Note that the data in panels E and F is the same data as in
Figure 2E and F, but sorted according to time-of-detection by PCR.
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35 days), intermediate (35 to 56 days), or late (56 to
77 days) after treatment (Figure 5C–F). That is, if we model
a constant force of infection and a normal distribution of
growth rates within a given age group, does time-to-
detection segregate individuals based on the parasite
growth rates? Figure 5C shows the predicted distribution of
parasite growth rates for children 1 to 4 years with infection
detected by microscopy (threshold of detection = 40 para-
sites/μL) at different times. It is clear that, as predicted by
the exponential survival curve, all groups are predicted
to have very similar parasite growth rates (i.e., almost
complete overlap of growth rates in Figure 5C), and the
major factor determining time-to-detection is simply
the random factor of when they initiated infection. By
Figure 5 Modelling the parasite growth rates in individuals detected at different times. The time-to-detection of infection by microscopy
(A, C, E) or PCR (B, D, F) was modelled assuming the same force of infection for all age groups. Parasite growth rates were assumed to follow a normal
distribution, with a different mean parasite growth rate for children aged 1 to 5 (blue lines) and adults >14 years (red lines). Growth rate was estimated
for individuals with infection detected in the first (14 to 35 days, light grey), second (35 to 56 days, medium grey), or last (56 to 77 days, dark grey)
third of the study period. For children (Panels C and D), very little difference in parasite growth is predicted depending on when their infections were
detected (curves for individuals detected early and late overlay each other in C and D). For adults, although the overall PMR is the same regardless of
how infection is detected, microscopy is better at sorting patients based on differences in their PMR. Thus, when infection is detected by microscopy
(detection threshold of 40 parasites/μL; Panel E), individuals infected later are predicted to have slower growth rates. When infection is detected by
PCR (detection threshold of 0.12 parasites/μL; Panel F), there is a smaller difference in PMR between individuals infected at different times.
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contrast, we predict that, using microscopy detection of
parasites in adults, individuals detected early have a higher
growth rate than individuals detected late (Figure 5E).
This occurs because the much slower growth of parasites
in older individuals means a much longer time between
infection and detection. Thus, although the time of detec-
tion is still affected by both the random time-to-initiation
(of blood-stage infection) and the subsequent growth rate,
in this case, the growth rate plays a more significant role
in determining time-to-detection. In our adult cohort
using microscopy detection, studying early-detected and
late-detected individuals allows identification of a more
resistant (slower parasite growth) late-infected group.
Using the more the sensitive PCR method to detect
infection (threshold of detection = 0.12 parasites/μL), the
situation changes. For the children, growth rate remains
overlapping for all time-to-infection groups (Figure 5D).
For the adults, time-to-infection is now a much less
powerful discriminator of parasite growth rate (Figure 5F
show greater overlap of growth rates than Figure 5E).
This occurs because the more sensitive detection reduces
the time between infection and detection. Importantly,
more sensitive detection reduces the delays induced by
growth rate. This has more of an effect for slow growing
infection (where delays are greater) than in fast growing
infections. As the time separation between fast- and slow-
growing infection narrows, the balance between the
contribution of random infection time and differences
in time from initiation to detection (due to blood-stage
growth) is shifted, and time-to-detection is less affected
by parasite growth rate.
Effects of different infection rates
The Kenyan cohort study we have analysed was performed
in an area of high transmission, with an estimated entomo-
logical inoculation rate of 0.8 per day [8], and new infection
rate of 0.066 per day [10]. As a result of this high infection
rate, the distribution of time-to-initiation of blood-
stage infections was quite short. Since the utility of
time-to-detection studies in separating individuals based
on growth rate of parasites is determined by the balance
between delays due to infection time and delays due to
subsequent growth rate, we investigated how differences
in infection rate in different cohorts would affect such
studies. We used the distributions in parasite growth rates
for different age groups estimated from the actual cohort
and then modelled the outcome for varying infection
rates. Figure 6 shows how different infection rates affect
the ability of time-to-infection studies to identify puta-
tively resistant individuals with slow parasite growth. In
the baseline scenario (yellow highlighted column in
Figure 6), the infection rate estimated from the cohort
was used. In this baseline scenario, we were able to
identify differences in growth rate in adults (Figure 6H),
but not in children (Figure 6E), based on time-to-
infection and microscopy detection of infection (as
shown also in Figure 5).
Differences in rate of initiation of infection will affect
the power of the time-to-infection approach to identify
more resistant or more susceptible individuals. If the
biting rate had been four times higher (half-life to infec-
tion of 2.5 days; Panel A), the children would have all
become infected much more quickly, meaning a shorter
average delay in time-to-initiation. Therefore, even given
the relatively narrow spread of parasite growth rates
observed in the children, separating early- versus late-
infected children would have segregated groups into
higher and lower average growth rates. That is, at high
infection rates, delays due to growth would have had a
proportionately much larger effect on time-to-detection,
and time-to-detection could be used to separate children
based on parasite growth rate at this high infection rate
(Figure 6D). As we lower infection rate to one quarter of
the baseline rate (half-life to infection = 40 days), this
reduces the differences in growth rate between early-
and late-infected children (Figure 6F).
In our field study (the baseline infection rate scenario),
adults infected early and late are expected to have different
average growth rates (when infection is detected by micros-
copy) (Figure 6H). At higher infection rates (Figure 6A,G),
time-to-detection remains a useful discriminator. However,
when we reduced the simulated infection rate to one quar-
ter of the baseline rate (half-life to infection of 40 days,
Figure 6C), this slower infection rate significantly reduces
the ability of the assay to discriminate subjects based on
time-to-detection (Figure 6F,I).
The ability of time-to-infection studies to establish the
more susceptible fraction of individuals (of a given age)
is determined by balance of delays induced ‘waiting to
be infected’ and delays in subsequent parasite growth.
For the children, the delays due to differences in growth
rates are small, because of the high growth rate, whereas
the expected delays are much higher in adults. Since
changing the infection rate does not change the PMR and
the same growth rates are used for all scenarios, the time
delay during growth from the liver stage to detection are
independent of the infection rate. Changing the infection
rate only changes the expected distribution of delays due
to time-to-initiation of infection. Whenever delays due to
time-to-initiation are greater than delays due to growth,
time-to-detection is largely random. Only when the delays
induced by growth rates are similar or higher than ran-
dom delays is time-to-initiation informative. For children,
this only occurs at a very high infection rate (Figure 6D).
For adults, with relatively large delays due to slow parasite
growth, PMR is the major determinant of delay at most
infection rates shown (Figure 6G–H), but is a smaller fac-
tor at low infection rates (Figure 6I).
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Discussion
Identifying naturally acquired immune responses that
are able to control parasite growth in the infected host
and reduce the frequency of clinical malaria provides a
potential avenue for the development of novel vaccin-
ation strategies. A number of investigators have studied
how baseline (pre-treatment) immune responses affect
time-to-infection after treatment [2,4]. This has also
been studied using time-to-infection from cohorts that
have naturally cleared malaria infection during the dry
season in areas of seasonal transmission [23,24]. The
underlying premise of such studies is that time-to-
infection is determined by the level of immunity of the
host. This assumption is supported by the fact that,
when stratified by age, older individuals in endemic
areas are consistently observed to have a longer time to
infection, and this delay is thought to be due to naturally
acquired immunity [5,25].
The association between age and time-to-infection sug-
gests that this is a useful correlate of naturally acquired
immunity. However, since the phenomenon of acquired
resistance with age and exposure is well-known, compar-
ing immune responses and time-to-infection in different
age groups seems rather laborious if the same information
can be obtained simply from date of birth. The major util-
ity of time-to-infection studies would be in differentiating
those of similar age and level of exposure, but who differ
in their levels of immunity. By identifying the differences
Figure 6 Modelling the effects of different infection rates on time-to-infection. Using the same model as in Figure 5, and assuming detection of
infection by microscopy, we investigated the effects of raising or lowering the infection rate. The centre column (Highlighted, B, E, H,) shows the same
infection rate as in Figure 5 (average time between bites = 10 days). Panel A shows the effects of a quadrupling of the infection rate. Similarly, Panel C
shows the effects of a quartering of the infection rate. For each infection rate, the predicted time-to-infection curves for adults (red) and children (blue)
are shown. Solid boxes in Panels A–C and solid lines in Panels D–I indicate an ‘early infection’ group, and dashed boxes and dashed lines indicate a
‘late infection’ group. The second row (D–F) shows the predicted difference in growth rates for children infected early versus late, at the different infection
rates. Although at high infection rates (D) some difference in average growth rate is predicted, this is lost at lower infection rates. For adults, there is a large
difference in growth rate between early- and late-infected groups at high infection rates (G). However, this difference is lost at very low infection rates
(Panel I).
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in immune responses between such ‘exposure matched’
individuals with different levels of protection, we should
be able to identify protective responses and antigens. By
comparing narrow age cohorts in localized geographical
areas, we may be able to identify such responses. However,
there are two major problems in this approach. First, it is
also likely that such narrow cohorts may also not differ
greatly in their levels of immunity, so a study design that
is very sensitive to small differences in susceptibility may
be required. Secondly, we are most interested in differing
levels of immunity and protection in young children, as
they are most at risk of clinical illness. However, since
children also have the highest parasite growth rates, they
are the most difficult population in which to identify dif-
ferences in time-to-infection due to differences in growth
rates. A major question is whether time-to-infection stud-
ies are sensitive enough to detect such differences in
immunity.
Herein, we have analysed data from a time-to-infection
cohort in Kenya in order to test whether such an approach
is able to differentiate varying levels of protection in a
group of age-matched individuals in an endemic area. We
find that when infection is detected by microscopy, time-
to-detection identifies adults with slower parasite growth
rates; however, it does not do this well in children. When
infection is detected using a more sensitive PCR approach,
more adults are detected as being infected (and infection
is detected earlier), but time-to-detection is less useful at
identifying individuals with slower parasite growth rates.
This analysis demonstrates that time-to-infection studies
are very sensitive to the distribution of parasite growth
rates in the group being studied, as well as the method of
detection of parasites. Microscopy detection is more sensi-
tive at segregating individuals based on parasite growth
rate than PCR detection is (and using a higher threshold
for detection is more sensitive still). However, in either
case, the rapid growth rates of parasites in children indi-
cate that it is very difficult to identify differences in growth
rates in children using this method.
Using a simulation approach, we investigated how
different rates of infection would affect the ability of time-
to-detection studies to sort individuals based on parasite
growth rate. This illustrates that choosing populations
with higher underlying infection rates will always lead
to a greater role for parasite growth rates in determin-
ing time-to-detection and thus be more sensitive at
sorting individuals based on time-to-detection. Similarly,
using a parasite-detection assay with a higher detection
threshold will lead to an increased effect of parasite
growth on time-to-detection, and thus also be more
sensitive.
The mechanisms of naturally acquired immunity are
generally divided into pre-erythrocytic versus blood-
stage immunity. Pre-erythrocytic immunity affects the
proportion of infectious bites that initiate blood-stage
infection by blocking infected bites prior to or in the
liver stages – thus affecting time-to-initiation (of blood-
stage infection). Blood-stage immunity affects the growth
rate of parasites in blood and hence the time from
infection to detection. Our modelling of time-to-infection
(Figure 6) reveals an inherent limitation of using such
approaches to study naturally acquired immunity. Since
so much of the outcome is determined by the random
time-to-infection, it is very difficult to determine immune
effects on parasite growth rate unless they are large. This
also has potential implications for studies using time-to-
infection as a means to assess vaccine effects on blood-
stage parasite growth, as these may have very limited
power to detect changes in time-to-detection. For studies
of liver-stage vaccines the problem is slightly different,
given that it is changes in the infection rate that are the
primary concern (the limitations of the statistical power of
such studies has been dealt with elsewhere [26]). In our
previous studies [5,10], we have found no evidence for
differences in infection rate with age and have shown
that measured differences in parasite growth rate with
age explain the observed differences in time-to-infection
for different age groups. Moreover, the good fit of an
exponential model of time-to-infection in children sug-
gests little effect of pre-erythrocytic immunity. Tran et al.
[23] have recently used a similar study and PCR detection
to also show no difference in time-to-detection in different
age groups. We note that differences in infection rate with
age may make it easier to detect differences in growth
rate in groups with a higher infection rate (Figure 6). It
is important to understand how time-to-infection studies
can be used to understand differences in parasite growth
rates both in naturally acquired immunity and in studies
of vaccination.
It is important to note that many studies of vaccine effi-
cacy rely on time-to-clinical-episode, rather than time-to-
infection. Infection and parasite growth are a pre-requisite
for a clinical episode, and thus time-to-infection may
still confound such studies. However, one approach to
reducing this effect is to restrict that analysis of clinical
episodes to individuals with demonstrated infection [27].
We note that, in our study, there were too few clinical
episodes in the 10-week monitoring interval to allow a
separate assessment of time-to-episode.
An important question is why, given the limited power
of time-to-infection studies, many studies have reported
significant associations between time-to-infection and
both pre-erythrocytic and blood-stage immunity? One
answer to this lies in the aggregation of age groups in
many studies. That is, in our analysis, we considered
relatively narrowly stratified age groups. If we pool all
age groups, it is relatively simple to show large differ-
ences in time-to-detection with age. Since immunity also
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varies with age (and exposure), it is obvious that in the
cohort as a whole, time-to-detection will correlate with
the accumulation of immunity with age. However, since
age is such a strong confounder here, it is questionable
what additional information the time-to-infection adds;
one could have simply correlated immune response with
age and presumably reached similar conclusions. More-
over, since immunity accumulates with age and exposure,
it is not possible to disentangle which immune responses
are simply the result of prolonged exposure and which
may be actually playing a role in reducing parasite growth
rates. Where we would ideally like to identify protective
responses would be in young children with similar levels
of exposure but with differences in either phenotype or
specificity of their immune response and who differ in
infection outcome. However, in young children, we predict
that time-to-infection studies are not able to discriminate
differences in blood-stage immunity and parasite growth
rates unless infection rates are extremely high.
Time-to-infection studies are only one approach to
identify susceptible and resistant individuals. Other
approaches include observing the presence or absence of
infection in a given time interval, or time to presence of
clinical malaria (rather than simply infection). We note
that if the underlying time to acquisition of infection is a
random process, then the presence or absence of infection
in a given time interval is also random. For example, if we
truncated our study at day 28 (Figure 1A), we would see
41% of children aged 1 to 4 infected and 59% uninfected.
However, whether children were in one group or another
would be due to the random distribution of time-to-
initiation. Similarly, time-to-clinical-malaria is dependent
on time-to-infection rate of parasite growth and under-
lying sensitivity to clinical malaria. Thus, the random
time-to-infection may still play a dominant role. We note
that others have suggested studying the rate of clinical
episodes only in individuals shown to be infected [27-29].
Interestingly, this is sometimes used as a measure to
decrease heterogeneity in exposure [30]. However, we
suggest that this may also have the effect of reducing
the impact of the random factor of when or whether
infection occurred, even in the presence of homogenous
levels of exposure. Further work is clearly required to
determine the role of random factors versus host factors
in studies of resistance to clinical malaria.
Detecting differences in parasite growth rate is difficult
using time-to-infection studies, since the random timing
of infection is often the major factor determining time-
to-infection. Human challenge studies provide a much
simpler approach for identifying differences in growth
rate, as time-of-infection is known. Since all patients are
infected synchronously, any delay between patients can
be attributed to either a reduced initial burden of infec-
tion, or reduced subsequent growth rate. Thus, both time-
to-detection and serial measurement of parasitemia can
be used to estimate growth rates following infection
[13,31,32]. Previous studies have shown major differences
in parasite growth rates in naïve versus exposed popula-
tions [33], and similar studies could, in principle, be used
to correlate prior immune responses with in vivo parasite
growth rates following natural infection. Alternatively, the
direct measurement of parasite growth rates in time-to-
infection studies provides a more direct way to identify
differences in blood-stage immunity than using time-to-
detection in these studies. Since time-to-infection studies
involve regular sampling for infection, if parasites can be
detected (by PCR) in two or more sequential samples,
then parasite growth rates can be directly estimated, inde-
pendent of when infection was initiated. Given the signifi-
cant limitations of time-to-infection studies in detecting
differences in both infection rates [26] or differences in
growth rates (illustrated here), we propose that direct
measurement of parasite growth rates in vivo will be a
much more useful correlate of immune control than time-
to-infection itself.
Conclusions
Many studies aim to identify resistance or susceptibility
to P. falciparum infection based upon the timing or
number of observed infections experienced by the patient.
However, depending on study design, most of the variation
in the timing and number of infections between age-
matched individuals may arise simply from the random
timing of when infection occurs. Careful attention to
study design is required to identify variation in individ-
uals’ resistance to P. falciparum infection.
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